The phosphorylation status of merlin in sporadic vestibular Schwannomas

Molecular and Cellular Biochemistry

Volumn 324, Issue 1-2, 2009, Pages 201-206

  Wang, Zhaoyan ^a   Lu, Yanjun ^b   Tang, Juanjuan ^b   Wang, Haojie ^b   Wu, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Cyclin dependent kinases; Merlin; Phosphorylated merlin; Ras; Schwannomas

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; MERLIN; P21 ACTIVATED KINASE; PROTEIN P27; RAC PROTEIN; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACOUSTIC NEURINOMA; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE MUTATION; HUMAN; HUMAN TISSUE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ADULT; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMIN 2; NEUROMA, ACOUSTIC; PHOSPHORYLATION; RAS PROTEINS; SIGNAL TRANSDUCTION; TUMOR BURDEN; YOUNG ADULT;

EID: 61549138113     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-0014-0     Document Type: Article

References (32)

1. Gutmann DH, Aylsworth A, Carey JC et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57. doi: 10.1001/jama.278.1.51
2. Antinheimo J, Sankila R, Carpen O et al (2000) Population-based analysis of sporadic and NF2-associated meningiomas and schwannomas. Neurology 54:71-76
3. Zwarthoff EC (1996) Neurofibromatosis and associated tumor suppressor genes. Pathol Res Pract 192:647-657
4. McClatchey AI, Saotome I, Mercer K et al (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12:1121-1133. doi: 10.1101/gad.12.8.1121
5. Giovannini M, Robanus-Maandag E, van der Valk M et al (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14:1617-1630
6. Murthy A, Gonzalez-Agosti C, Cordero E et al (1998) NHE-RF, a regulatory cofactor for Na+-H+ exchange, is a common interactor for merlin and ERM proteins. J Biol Chem 273:1273-1276. doi: 10.1074/jbc.273.3.1273
7. Sainio M, Zhao F, Heiska L et al (1997) Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci 110:2249-2260
8. Hitotsumatsu T, Iwaki T, Kitamoto T et al (1997) Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study. Acta Neuropathol 93:225-232. doi: 10.1007/ s004010050608
9. Huynh DP, Mautner V, Baser ME et al (1997) Immunohistochemical detection of schwannomin and neurofibromin in vestibular Schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol 56:382-390. doi: 10.1097/ 00005072-199704000-00007
10. Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L et al (1997) Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system. J Neuropathol Exp Neurol 56:735-742. doi: 10.1097/00005072-199705000-00004
11. Lutchman M, Rouleau GA (1995) The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270-2274
12. Tikoo A, Varga M, Ramesh V et al (1994) An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem 269:23387-23390
13. Morrison H, Sherman LS, Legg J et al (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968-980. doi: 10.1101/gad.189601
14. Schulze KM, Hanemann CO, Muller HW, Hanenberg H (2002) Transduction of wild-type merlin into human Schwannoma cells decreases Schwannoma cell growth and induces apoptosis. Hum Mol Genet 11:69-76. doi: 10.1093/hmg/ 11.1.69
15. Sherman L, Xu HM, Geist RT et al (1997) Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene 15:2505-2509. doi: 10.1038/sj.onc.1201418
16. Elledge SJ, Winston J, Harper JW (1996) A question of balance: The role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388-392. doi: 10.1016/0962-8924(96)10030-1
17. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature 371:257-261. doi: 10.1038/ 371257a0
18. Harper JW, Adami GR, Wei N et al (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclindependent kinases. Cell 75:805-816. doi: 10.1016/0092-8674(93)90499-G
19. Reynisdóttir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-b. Genes Dev 9:1831-1845. doi: 10.1101/gad.9.15.1831
20. Tang JJ, Shen C, Lu YJ (2006) Requirement for pre-existing of p21 to prevent doxorubicin-induced apoptosis through inhibition of caspase-3 activation. Mol Cell Biochem 291:139-144. doi: 10.1007/s11010-006-9206-7
21. Lu YJ, Tatsuka M, Takebe H, Yagi T (2000) Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells. Mol Carcinog 29:1-7 doi: 10.1002/ 1098-2744(200009)29:13.0.CO;2-A
22. Lu YJ, Yamagishi N, Yagi T, Takebe H (1998) Mutated p21WAF1/CIP1/SDI1 lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells. Oncogene 16:705-712. doi: 10.1038/ sj.onc.1201585
23. Morrison H, Sperka T, Manent J et al (2007) Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Res 67:520-527. doi: 10.1158/0008-5472.CAN-06-1608
24. Okada T, Lopez-Lago M, Giancotti FG (2005) Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 171:361-371. doi: 10.1083/jcb.200503165
25. Lu YJ, Yamagishi N, Miyakoshi J et al (1996) Sites and types of UV-induced mutations leading to inactivation of the growth-arresting activity in p21 (waf1)(sdi1/cip1/waf1) cDNA. Carcinogenesis 17:2343-2345. doi: 10.1093/carcin/17.11.2343
26. Xiao GH, Gallagher R, Shetler J et al (2005) The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression. Mol Cell Biol 25:2384-2394. doi: 10.1128/MCB.25.6.2384-2394.2005
27. Jin H, Sperka Y, Herrlich P, Morrison H (2006) Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature 442:576-579. doi: 10.1038/nature04856
28. Kim H, Lim JY, Kim YH et al (2002) Inhibition of Ras-mediated activator protein 1 activity and cell growth by merlin. Mol Cells 14:108-114
29. Shaw RJ, Paez JG, Curto M et al (2001) The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 1:63-72. doi: 10.1016/ S1534-5807(01)00009-0
30. Xiao GH, Beeser A, Chernoff J, Testa JR (2002) p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem 277:883-886. doi: 10.1074/jbc.C100553200
31. Chadee DN, Xu DZ, Hung G et al (2006) Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proc Natl Acad Sci USA 103:4463-4468. doi: 10.1073/pnas.0510651103
32. Rong LR, Tang XL, Gutmann DH, Ye K (2004) Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE. Proc Natl Acad Sci USA 101:18200-18205. doi: 10.1073/ pnas.0405971102